Orkambinitaliasubito,
Original Article from The New England Journal of Medicine — Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous…
Original Article from The New England Journal of Medicine — Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous…
#FDA recently approved #Orkambi (lumacaftor 200mg/ivacaftor 125mg; by Vertex) in patients ≥ 12 years with homozygous F508del…
FDA approves new treatment for Cystic…
A new chapter in therapy for cystic fibrosis (The Lancet) http://goo.gl/k9zMal